Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPRIT: Subcutaneous Proleukin in HIV-1 Infection
NCT00004978Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2000
- Primary completion
- Nov 2008
- Modality
- Cytokines & Interferons
- Countries
- 25
01
Overview
A Phase 3 trial of aldesleukin in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2000; status: completed.
02
Drugs
aldesleukin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00004978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004978.